Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

ClinicalTrials.gov ID: NCT00050843

Public ClinicalTrials.gov record NCT00050843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 10:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to determine the efficacy of thalidomide for the treatment of anemia in patients with myelodysplastic syndromes (MDS).

Study identification

NCT ID
NCT00050843
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene Corporation
Industry
Enrollment
220 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2001
Primary completion
Not listed
Completion
Jan 31, 2004
Last update posted
Jun 23, 2005

2001 – 2004

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
38
Facility City State ZIP Site status
Scripps Cancer Center La Jolla California 93037 —
Comprehensive Cancer Centers of the Desert Palm Springs California 92262 —
Desert Hematology Oncology Medical Group INC Rancho Mirage California 92270 —
Whittingham Cancer Center Norwalk Connecticut 06856 —
VA Connecticut Healthcare System West Haven Connecticut 06516 —
Southeast Florida Hematology-Oncology Fort Lauderdale Florida 33308 —
Florida Cancer Specialists Fort Myers Florida 33901 —
Northwest Medical Specialists Arlington Heights Illinois 60004 —
Oncology Associates Cedar Rapids Iowa 52403 —
Beaumont Cancer Center Royal Oak Michigan 48073 —
SMDC Health Systems Duluth Minnesota 55805 —
Mayo Clinic Rochester Minnesota 55905 —
Jackson Oncology Associates PLLC Jackson Mississippi 39202 —
Hematology Oncology Consultants Inc St Louis Missouri 63136 —
Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Hematology Oncology Associates of NJ Paramus New Jersey 07652 —
Summit Medical Group/Overlook Oncology Center Summit New Jersey 07901 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Memorial Sloan Kettering Cancer Ctr New York New York 10021 —
VAMC Northport Northport New York 11768 —
University of Rochester Cancer Center Rochester New York 14642 —
South Shore Hem-Onc Assoc. PA Rockville Centre New York 11570 —
Staten Island Unversity Hospital Staten Island New York 10305 —
Westchester County Medical Center Valhalla New York 10595 —
Buffalo Medical Group PC Williamsville New York 14221 —
Northwestern Carolina Hematology Oncology PA Hickory North Carolina 28602 —
Wake Forest Univ School of Medicine Winston-Salem North Carolina 27157-1082 —
Oncology/Hematology Care Inc Cincinnati Ohio 45246 —
Oregon Health & Science University Portland Oregon 97201 —
Medical Oncology Associates Kingston Pennsylvania 18704 —
Lancaster Cancer Center LTD Lancaster Pennsylvania 17605 —
MCP Hahnemann University Philadelphia Pennsylvania 19129 —
Western Pennsylvania Cancer Institute Pittsburgh Pennsylvania 15224 —
Texas Oncology PA-BMT Center Dallas Texas 75230 —
Central Utah Medical Clinic Provo Utah 84604 —
InterMountain Hematology/Oncology Salt Lake City Utah 84122 —
Swedish Cancer Institute Seattle Washington 98104 —
Yakima Regional CancerCenter Yakima Washington 98902 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00050843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00050843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →